Detalles de la búsqueda
1.
Corrigendum to "Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice".
Mediators Inflamm
; 2016: 3151986, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27829706
2.
Irbesartan Ameliorates Diabetic Nephropathy by Suppressing the RANKL-RANK-NF-κB Pathway in Type 2 Diabetic db/db Mice.
Mediators Inflamm
; 2016: 1405924, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26880862
3.
Single laparoscopic hepatectomy for a 11-cm hepatocellular carcinoma.
J Formos Med Assoc
; 111(8): 461-2, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22939666
4.
Cyclopropanyldehydrocostunolide LJ attenuates high glucose-induced podocyte injury by suppressing RANKL/RANK-mediated NF-κB and MAPK signaling pathways.
J Diabetes Complications
; 30(5): 760-9, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27052152
5.
Metadherin facilitates podocyte apoptosis in diabetic nephropathy.
Cell Death Dis
; 7(11): e2477, 2016 11 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-27882943
6.
[Effect of nitrotyrosine on renal expressions of NF-κB, MCP-1 and TGF-ß1 in rats with diabetic nephropathy].
Nan Fang Yi Ke Da Xue Xue Bao
; 33(3): 346-50, 2013 Mar.
Artículo
en Zh
| MEDLINE | ID: mdl-23529229
7.
[Effects of Shenkangwan on renal expressions of angiotensin II and its type I receptor in rats with early diabetic nephropathy].
Nan Fang Yi Ke Da Xue Xue Bao
; 30(4): 805-9, 2010 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-20423855
8.
[Effects of angiotensin II receptor antagonist on rat podocyte injury in early diabetic nephropathy].
Nan Fang Yi Ke Da Xue Xue Bao
; 27(4): 505-8, 2007 Apr.
Artículo
en Zh
| MEDLINE | ID: mdl-17545045
Resultados
1 -
8
de 8
1
Próxima >
>>